Skip to main content
CPIX logo

CPIX

Cumberland Pharmaceuticals Inc.

$5.74

8.87%

Trade Ideas Performance

Latest Closed Trade Idea

$5.74

8.87%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

8

Social

1

About

Events of Cumberland Pharmaceuticals Inc. (CPIX)

In October 2026, CPIX shares fell significantly following the release of top-line results from its Phase 2a ASSIST-SSc trial for oral ifetroban, which did not show clear efficacy signals, despite the drug being well-tolerated. However, the company's announcement of plans to file a New Drug Application (NDA) for its Ifetroban DMD program led to stock increases, though the FDA later questioned the evidence of benefit. In August 2026, the company reported a Q2 2026 loss from continuing operations of approximately $3.1 million, causing a stock decline, and also announced a delay in Duchenne heart trial data. July 2026 saw stock increases. Cumberland Pharmaceuticals is scheduled to announce a company update and Q3 2026 financial results around November 10, 2026, with cautious sentiment as shares trade below the 50-day moving average due to recent pipeline news.

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)